Theranos Lab May Pose Threat to Patient Safety

The most pressing concern involves Theranos’s hematology testing, according the letter, where the company’s failure to meet regulators’ clinical standards could be harmful to patients. Those tests would typically include counts of red and white blood cells or the monitoring of patients who are on blood thinners.